Compile Data Set for Download or QSAR
maximum 50k data
Found 44 Enz. Inhib. hit(s) with all data for entry = 10250
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522987(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522989(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523005(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523003(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522991(1-(4-(4-amino-7-(2- hydroxy-2- methylpropyl)-7H- p...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523015(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522958(1-(4-(4-amino-7- (oxetan-3-yl)-7H- pyrrolo[2,3- d]...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523007(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  225nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522959(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522999(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522995(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523019(1-(4-(4-amino-7- cyclobutyl-7H- pyrrolo[2,3- d]pyr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523022(1-(4-(4-amino-7-(1- methylpyrrolidin-3-yl)- 7H-pyr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523006(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523004(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523002(1-(4-(4-amino-7-(1- methylpiperidin-4-yl)- 7H-pyrr...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522990(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522988(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  400nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523001(1-(4-(4-amino-7- (pyridin-4-yl)-7H- pyrrolo[2,3- d...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523023(1-(4-(4-amino-7- cyclobutyl-7H- pyrrolo[2,3- d]pyr...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523014(1-(5-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522972(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523000(1-(4-(4-amino-7- (pyridin-3-yl)-7H- pyrrolo[2,3- d...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523012(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522983(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523009(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523008(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50:  1.00E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523010(1-(6-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523016(1-(5-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523020(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3 - d]p...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522992(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523024(1-(6-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523025(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523026(US11161852, Compound 62 | US11713321, Example 62)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522998(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523013(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3 - d]p...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522993(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3 - d]p...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522994(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523021(1-(4-(4-amino-7-c yclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523018(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522996(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523017(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM522997(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetSerine/threonine-protein kinase Nek7(Homo sapiens (Human))
Halia Therapeutics

US Patent
LigandPNGBDBM523011(1-(4-(4-amino-7- cyclopropyl-7H- pyrrolo[2,3- d]py...)
Affinity DataIC50: >1.50E+3nMAssay Description:Casein substrate (from bovine milk, hydrolyzed and partially dephosphorylated mixture of α, β and a caseins, obtained from Sigma Aldrich, c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent